If you’ve spent any time reading OrthoStreams, you know my core philosophy: Business Model > Product.
When I first wrote about SI Joint Fusion market years ago, it was the wild west. Fast-forward to 2026, and the warning signs have materialized into a harsh reality. The SI fusion space has officially devolved into a hyper-commoditized, over-differentiated tech trap.
We have officially exited the "FOMO" era of easy capital and shiny implant features. Today, if your innovation doesn’t solve an economic, throughput, or workflow bottleneck for the Ambulatory Surgical Center (ASC), it isn't compounding your growth—it’s just accumulating dust.
The Power of a Monopoly: In modern orthopedics, true scale belongs to those who eliminate operational friction. If you are launching yet another "me-too" lateral titanium screw with a slightly modified porous coating, you aren't building a business; you are volunteering for a price war.
The Macro View: Market Explosion vs. Price Erosion
Let’s look at the numbers. The pure clinical demand for SI joint intervention remains massive. Roughly 25% of all chronic lower back pain can be traced back to SI joint dysfunction.
While a half-billion-dollar...
